Direct 8(a) award of 3-year, time & materials type contract to kaiva to provide tplc advisory program (TAP) for the cdrh

Active Definitive Contract Awarded Last action

Contract number
75F40124C00092
Awardee
Awarding agency
Obligated
$4,246,242

Award facts

Opportunity
  • 75F40124R00143 Solicitation number
Contract value 100% obligated
$4,246,242.32 Current and potential, with all options
Completion date 70% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Time and Materials
Place of performance
Calverton, MD 20705, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00003 · Tplc advisory program (TAP) for the cdrh $1,455,909
Exercise an Option P00002 $1,415,017
Terminate for Convenience P00001 · EOI::ending radical and wasteful government DEI programs and preferencing (january 20, 2025)::EOI notice of termination for convenience $0
Original award $1,375,316

About this award

The Food and Drug Administration awarded a $4.25 million definitive contract to Kaiva Strategies, LLC, a tribally-owned, minority-owned 8(a) small business, for the TPLC Advisory Program (TAP) supporting the Center for Devices and Radiological Health on September 10, 2024, under a direct 8(a) award.

The contract is a three-year time-and-materials engagement with an ultimate completion date of September 11, 2027. Place of performance is Calverton, MD. The originating solicitation calls for advisory program support to CDRH.

Under Service Contract Inventory reporting, the contract invoiced $57 thousand in FY2024 (0.1 FTEs, 247 contractor hours) and $912 thousand in FY2025 (1.0 FTEs, 1,991 contractor hours), with derived government-paid rates of $230.83 per hour in FY2024 and $458.30 per hour in FY2025. In FY2025, 100 percent of contractor hours were subcontracted out through one subcontractor. The hourly rate trend is rising year-over-year.

Quick answers

Who was awarded contract 75F40124C00092?

75F40124C00092 was awarded to Kaiva Strategies, LLC by Food and Drug Administration (Department of Health and Human Services) on September 10, 2024.

How much is contract 75F40124C00092 worth?

The government has obligated $4,246,242 on 75F40124C00092.

Was contract 75F40124C00092 competed?

The extent of competition for 75F40124C00092 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award